-
1
-
-
77957734604
-
Rejection of the kidney allograft
-
Nankivell BJ, Alexander SI: Rejection of the kidney allograft. N Engl J Med 363: 1451- 1462, 2010.
-
(2010)
N Engl J Med
, vol.363
, pp. 1451-1462
-
-
Nankivell, B.J.1
Alexander, S.I.2
-
2
-
-
84856411838
-
Understanding the causes of kidney transplant failure: The dominant role of antibody-mediated rejection and nonadherence
-
Sellarés J, de Freitas DG, Mengel M, Reeve J, Einecke G, Sis B, Hidalgo LG, Famulski K, Matas A, Halloran PF: Understanding the causes of kidney transplant failure: The dominant role of antibody-mediated rejection and nonadherence. Am J Transplant 12: 388-399, 2012.
-
(2012)
Am J Transplant
, vol.12
, pp. 388-399
-
-
Sellarés, J.1
De Freitas, D.G.2
Mengel, M.3
Reeve, J.4
Einecke, G.5
Sis, B.6
Hidalgo, L.G.7
Famulski, K.8
Matas, A.9
Halloran, P.F.10
-
3
-
-
70350131760
-
Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure
-
Einecke G, Sis B, Reeve J, Mengel M, Campbell PM, Hidalgo LG, Kaplan B, Halloran PF: Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant 9: 2520- 2531, 2009.
-
(2009)
Am J Transplant
, vol.9
, pp. 2520-2531
-
-
Einecke, G.1
Sis, B.2
Reeve, J.3
Mengel, M.4
Campbell, P.M.5
Hidalgo, L.G.6
Kaplan, B.7
Halloran, P.F.8
-
4
-
-
77955607610
-
Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation
-
Lefaucheur C, Loupy A, Hill GS, Andrade J, Nochy D, Antoine C, Gautreau C, Charron D, Glotz D, Suberbielle-Boissel C: Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation. J Am Soc Nephrol 21: 1398-1406, 2010.
-
(2010)
J Am Soc Nephrol
, vol.21
, pp. 1398-1406
-
-
Lefaucheur, C.1
Loupy, A.2
Hill, G.S.3
Andrade, J.4
Nochy, D.5
Antoine, C.6
Gautreau, C.7
Charron, D.8
Glotz, D.9
Suberbielle-Boissel, C.10
-
5
-
-
84941998299
-
Long term outcomes of transplantation using kidneys fromexpanded criteria donors: Prospective, population based cohort study
-
Aubert O, Kamar N, Vernerey D, Viglietti D, Martinez F, Duong-Van-Huyen JP, Eladari D, Empana JP, Rabant M, Verine J, Rostaing L, Congy N, Guilbeau-Frugier C, Mourad G, Garrigue V, Morelon E, Giral M, Kessler M, Ladrière M, Delahousse M, Glotz D, Legendre C, Jouven X, Lefaucheur C, Loupy A: Long term outcomes of transplantation using kidneys fromexpanded criteria donors: Prospective, population based cohort study. BMJ 351: h3557, 2015.
-
(2015)
BMJ
, vol.351
, pp. h3557
-
-
Aubert, O.1
Kamar, N.2
Vernerey, D.3
Viglietti, D.4
Martinez, F.5
Duong-Van-Huyen, J.P.6
Eladari, D.7
Empana, J.P.8
Rabant, M.9
Verine, J.10
Rostaing, L.11
Congy, N.12
Guilbeau-Frugier, C.13
Mourad, G.14
Garrigue, V.15
Morelon, E.16
Giral, M.17
Kessler, M.18
Ladrière, M.19
Delahousse, M.20
Glotz, D.21
Legendre, C.22
Jouven, X.23
Lefaucheur, C.24
Loupy, A.25
more..
-
6
-
-
33644885700
-
A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody
-
Stegall MD, Gloor J, Winters JL, Moore SB, Degoey S: A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody. Am J Transplant 6: 346-351, 2006.
-
(2006)
Am J Transplant
, vol.6
, pp. 346-351
-
-
Stegall, M.D.1
Gloor, J.2
Winters, J.L.3
Moore, S.B.4
Degoey, S.5
-
7
-
-
47549105407
-
Rituximab and intravenous immune globulin for desensitization during renal transplantation
-
Vo AA, Lukovsky M, Toyoda M, Wang J, Reinsmoen NL, Lai CH, Peng A, Villicana R, Jordan SC: Rituximab and intravenous immune globulin for desensitization during renal transplantation. N Engl J Med 359: 242- 251, 2008.
-
(2008)
N Engl J Med
, vol.359
, pp. 242-251
-
-
Vo, A.A.1
Lukovsky, M.2
Toyoda, M.3
Wang, J.4
Reinsmoen, N.L.5
Lai, C.H.6
Peng, A.7
Villicana, R.8
Jordan, S.C.9
-
8
-
-
77953360290
-
Combined posttransplant prophylactic IVIg/anti-CD 20/plasmapheresis in kidney recipients with preformed donor-specific antibodies: A pilot study
-
Loupy A, Suberbielle-Boissel C, Zuber J, Anglicheau D, Timsit MO, Martinez F, Thervet E, Bruneval P, Charron D, Hill GS, Nochy D, Legendre C: Combined posttransplant prophylactic IVIg/anti-CD 20/plasmapheresis in kidney recipients with preformed donor-specific antibodies: A pilot study. Transplantation 89: 1403-1410, 2010.
-
(2010)
Transplantation
, vol.89
, pp. 1403-1410
-
-
Loupy, A.1
Suberbielle-Boissel, C.2
Zuber, J.3
Anglicheau, D.4
Timsit, M.O.5
Martinez, F.6
Thervet, E.7
Bruneval, P.8
Charron, D.9
Hill, G.S.10
Nochy, D.11
Legendre, C.12
-
9
-
-
79960856720
-
Desensitization in HLA incompatible kidney recipients and survival
-
Montgomery RA, Lonze BE, King KE, Kraus ES, Kucirka LM, Locke JE, Warren DS, Simpkins CE, Dagher NN, Singer AL, Zachary AA, Segev DL: Desensitization in HLAincompatible kidney recipients and survival. N Engl J Med 365: 318-326, 2011.
-
(2011)
N Engl J Med
, vol.365
, pp. 318-326
-
-
Montgomery, R.A.1
Lonze, B.E.2
King, K.E.3
Kraus, E.S.4
Kucirka, L.M.5
Locke, J.E.6
Warren, D.S.7
Simpkins, C.E.8
Dagher, N.N.9
Singer, A.L.10
Zachary, A.A.11
Segev, D.L.12
-
10
-
-
84896695537
-
Time course of pathologic changes in kidney allografts of positive crossmatch HLA incompatible transplant recipients
-
Bagnasco SM, Zachary AA, Racusen LC, Arend LJ, Carter-Monroe N, Alachkar N, Nazarian SM, Lonze BE, Montgomery RA, Kraus ES: Time course of pathologic changes in kidney allografts of positive crossmatch HLAincompatible transplant recipients. Transplantation 97: 440-445, 2014.
-
(2014)
Transplantation
, vol.97
, pp. 440-445
-
-
Bagnasco, S.M.1
Zachary, A.A.2
Racusen, L.C.3
Arend, L.J.4
Carter-Monroe, N.5
Alachkar, N.6
Nazarian, S.M.7
Lonze, B.E.8
Montgomery, R.A.9
Kraus, E.S.10
-
11
-
-
85190348460
-
-
Rapport annuel de l'Agence de la biomédecine. Available at:, Accessed September 29, 2016
-
Rapport annuel de l'Agence de la biomédecine. 2015. Agence Biomédecine: Cristal. Available at: http://www.sipg.sante.fr/portail/Accessed September 29, 2016.
-
(2015)
Agence Biomédecine: Cristal
-
-
-
12
-
-
84919347902
-
-
Organ Procurement and Transplantation Network/Scientific Registry of Transplant Recipients. Available at:, Accessed June 1
-
Organ Procurement and Transplantation Network/Scientific Registry of Transplant Recipients. Annual report 2012. Available at: https://optn.transplant.hrsa.gov/data/viewdata-reports/annual-report/Accessed June 1, 2014.
-
(2014)
Annual Report 2012
-
-
-
13
-
-
84960466211
-
Survival benefit with kidney transplants from HLA-incompatible live donors
-
Orandi BJ, Luo X, Massie AB, Garonzik-Wang JM, Lonze BE, Ahmed R, Van Arendonk KJ, Stegall MD, Jordan SC, Oberholzer J, Dunn TB, Ratner LE, Kapur S, Pelletier RP, Roberts JP, Melcher ML, Singh P, Sudan DL, Posner MP, El-Amm JM, Shapiro R, Cooper M, Lipkowitz GS, Rees MA, Marsh CL, Sankari BR, Gerber DA, Nelson PW, Wellen J, Bozorgzadeh A, Gaber A O, Montgomery RA, Segev DL: Survival benefit with kidney transplants from HLA-incompatible live donors. N Engl J Med 374: 940-950, 2016.
-
(2016)
N Engl J Med
, vol.374
, pp. 940-950
-
-
Orandi, B.J.1
Luo, X.2
Massie, A.B.3
Garonzik-Wang, J.M.4
Lonze, B.E.5
Ahmed, R.6
Van Arendonk, K.J.7
Stegall, M.D.8
Jordan, S.C.9
Oberholzer, J.10
Dunn, T.B.11
Ratner, L.E.12
Kapur, S.13
Pelletier, R.P.14
Roberts, J.P.15
Melcher, M.L.16
Singh, P.17
Sudan, D.L.18
Posner, M.P.19
El-Amm, J.M.20
Shapiro, R.21
Cooper, M.22
Lipkowitz, G.S.23
Rees, M.A.24
Marsh, C.L.25
Sankari, B.R.26
Gerber, D.A.27
Nelson, P.W.28
Wellen, J.29
Bozorgzadeh, A.30
Gaber, A.O.31
Montgomery, R.A.32
Segev, D.L.33
more..
-
14
-
-
84960351831
-
HLA-incompatible kidney transplantation-worth the risk?
-
Rostaing LP, Malvezzi P: HLA-incompatible kidney transplantation-worth the risk? N Engl J Med 374: 982-984, 2016.
-
(2016)
N Engl J Med
, vol.374
, pp. 982-984
-
-
Rostaing, L.P.1
Malvezzi, P.2
-
15
-
-
70350131763
-
De novo donor-specificantibodyat the time of kidney transplant biopsy associates with microvascular pathology and late graft failure
-
Hidalgo LG, Campbell PM, Sis B, Einecke G, Mengel M, Chang J, Sellares J, Reeve J, Halloran PF: De novo donor-specificantibodyat the time of kidney transplant biopsy associates with microvascular pathology and late graft failure. Am J Transplant 9: 2532-2541, 2009.
-
(2009)
Am J Transplant
, vol.9
, pp. 2532-2541
-
-
Hidalgo, L.G.1
Campbell, P.M.2
Sis, B.3
Einecke, G.4
Mengel, M.5
Chang, J.6
Sellares, J.7
Reeve, J.8
Halloran, P.F.9
-
16
-
-
84860473178
-
Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant
-
Wiebe C, Gibson IW, Blydt-Hansen TD, Karpinski M, Ho J, Storsley LJ, Goldberg A, Birk PE, Rush DN, Nickerson PW: Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant. Am J Transplant 12: 1157-1167, 2012.
-
(2012)
Am J Transplant
, vol.12
, pp. 1157-1167
-
-
Wiebe, C.1
Gibson, I.W.2
Blydt-Hansen, T.D.3
Karpinski, M.4
Ho, J.5
Storsley, L.J.6
Goldberg, A.7
Birk, P.E.8
Rush, D.N.9
Nickerson, P.W.10
-
17
-
-
84928035596
-
The molecular landscape of antibody-mediated kidney transplant rejection: Evidence for NK involvement through CD16a Fc receptors
-
Venner JM, Hidalgo LG, Famulski KS, Chang J, Halloran PF: The molecular landscape of antibody-mediated kidney transplant rejection: Evidence for NK involvement through CD16a Fc receptors. Am J Transplant 15: 1336-1348, 2015.
-
(2015)
Am J Transplant
, vol.15
, pp. 1336-1348
-
-
Venner, J.M.1
Hidalgo, L.G.2
Famulski, K.S.3
Chang, J.4
Halloran, P.F.5
-
18
-
-
85008959098
-
The molecular phenotypes of rejection in kidney transplant biopsies
-
Halloran PF, Famulski K, Reeve J: The molecular phenotypes of rejection in kidney transplant biopsies. Curr Opin Organ Transplant 20: 359-367, 2015.
-
(2015)
Curr Opin Organ Transplant
, vol.20
, pp. 359-367
-
-
Halloran, P.F.1
Famulski, K.2
Reeve, J.3
-
19
-
-
77954944540
-
NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: Evidence for NK cell involvement in antibody-mediated rejection
-
Hidalgo LG, Sis B, Sellares J, Campbell PM, Mengel M, Einecke G, Chang J, Halloran PF: NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: Evidence forNK cell involvement in antibody-mediated rejection. Am J Transplant 10: 1812-1822, 2010.
-
(2010)
Am J Transplant
, vol.10
, pp. 1812-1822
-
-
Hidalgo, L.G.1
Sis, B.2
Sellares, J.3
Campbell, P.M.4
Mengel, M.5
Einecke, G.6
Chang, J.7
Halloran, P.F.8
-
20
-
-
84921474658
-
Quantifying renal allograft loss following early anti body mediated rejection
-
Orandi BJ, Chow EH, Hsu A, Gupta N, Van Arendonk KJ, Garonzik-Wang J M, Montgomery JR, Wickliffe C, Lonze BE, Bagnasco SM, Alachkar N, Kraus ES, Jackson AM, Montgomery RA, Segev DL: Quantifying renal allograft loss following early antibodymediated rejection. Am J Transplant 15: 489-498, 2015.
-
(2015)
Am J Transplant
, vol.15
, pp. 489-498
-
-
Orandi, B.J.1
Chow, E.H.2
Hsu, A.3
Gupta, N.4
Van, A.K.J.5
Garonzik-Wang, J.M.6
Montgomery, J.R.7
Wickliffe, C.8
Lonze, B.E.9
Bagnasco, S.M.10
Alachkar, N.11
Kraus, E.S.12
Jackson, A.M.13
Montgomery, R.A.14
Segev, D.L.15
-
21
-
-
65249111644
-
Comparison of combination plasmapheresis/IVIg/anti-CD20 versus high-dose IVIg in the treatment of antibody-mediated rejection
-
Lefaucheur C, Nochy D, Andrade J, Verine J, Gautreau C, Charron D, Hill GS, Glotz D, Suberbielle-Boissel C: Comparison of combination plasmapheresis/IVIg/anti-CD20 versus high-dose IVIg in the treatment of antibody-mediated rejection. Am J Transplant 9: 1099-1107, 2009.
-
(2009)
Am J Transplant
, vol.9
, pp. 1099-1107
-
-
Lefaucheur, C.1
Nochy, D.2
Andrade, J.3
Verine, J.4
Gautreau, C.5
Charron, D.6
Hill, G.S.7
Glotz, D.8
Suberbielle-Boissel, C.9
-
22
-
-
79958245423
-
Early and late acute antibody-mediated rejection differ immunologically and in response to proteasome inhibition
-
Walsh RC, Brailey P, Girnita A, Alloway RR, Shields AR, Wall GE, Sadaka BH, Cardi M, Tevar A, Govil A, Mogilishetty G, Roy- Chaudhury P, Woodle ES: Early and late acute antibody-mediated rejection differ immunologically and in response to proteasome inhibition. Transplantation 91: 1218-1226, 2011.
-
(2011)
Transplantation
, vol.91
, pp. 1218-1226
-
-
Walsh, R.C.1
Brailey, P.2
Girnita, A.3
Alloway, R.R.4
Shields, A.R.5
Wall, G.E.6
Sadaka, B.H.7
Cardi, M.8
Tevar, A.9
Govil, A.10
Mogilishetty, G.11
Roy, C.P.12
Woodle, E.S.13
-
23
-
-
0021972734
-
The quality of life of patients with end-stage renal disease
-
Evans RW, Manninen DL, Garrison LP Jr., Hart LG, Blagg CR, Gutman RA, Hull AR, Lowrie EG: The quality of life of patients with end-stage renal disease. N Engl JMed 312: 553-559, 1985.
-
(1985)
N Engl JMed
, vol.312
, pp. 553-559
-
-
Evans, R.W.1
Manninen, D.L.2
Garrison, L.P.3
Hart, L.G.4
Blagg, C.R.5
Gutman, R.A.6
Hull, A.R.7
Lowrie, E.G.8
-
24
-
-
0027305120
-
Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients
-
Port FK, Wolfe RA, Mauger EA, Berling DP, Jiang K: Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients. JAMA 270: 1339-1343, 1993.
-
(1993)
JAMA
, vol.270
, pp. 1339-1343
-
-
Port, F.K.1
Wolfe, R.A.2
Mauger, E.A.3
Berling, D.P.4
Jiang, K.5
-
25
-
-
84959543767
-
Identifying sub phenotypes of anti body mediated rejection in kidney transplants
-
Halloran PF, Merino Lopez M, Barreto Pereira A: Identifying sub phenotypes of anti body mediated rejection in kidney transplants. Am J Transplant 16: 908-920, 2016.
-
(2016)
Am J Transplant
, vol.16
, pp. 908-920
-
-
Halloran, P.F.1
Merino, L.M.2
Barreto, P.A.3
-
26
-
-
75749119257
-
Banff '09 meeting report: Antibody mediated graft deterioration and implementation of Banff working groups
-
Sis B, MengelM, Haas M, Colvin RB, Halloran PF, Racusen LC, Solez K, Baldwin WM 3rd, Bracamonte ER, Broecker V, Cosio F, Demetris AJ, Drachenberg C, Einecke G, Gloor J, Glotz D, Kraus E, Legendre C, Liapis H, Mannon RB, Nankivell BJ, Nickeleit V, Papadimitriou JC, Randhawa P, Regele H, Renaudin K, Rodriguez ER, Seron D, Seshan S, Suthanthiran M, Wasowska BA, Zachary A, Zeevi A: Banff '09 meeting report: Antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant 10: 464-471, 2010.
-
(2010)
Am J Transplant
, vol.10
, pp. 464-471
-
-
Sis, B.1
Menge, L.M.2
Haas, M.3
Colvin, R.B.4
Halloran, P.F.5
Racusen, L.C.6
Solez, K.7
Baldwin, W.M.8
Bracamonte, E.R.9
Broecker, V.10
Cosio, F.11
Demetris, A.J.12
Drachenberg, C.13
Einecke, G.14
Gloor, J.15
Glotz, D.16
Kraus, E.17
Legendre, C.18
Liapis, H.19
Mannon, R.B.20
Nankivell, B.J.21
Nickeleit, V.22
Papadimitriou, J.C.23
Randhawa, P.24
Regele, H.25
Renaudin, K.26
Rodriguez, E.R.27
Seron, D.28
Seshan, S.29
Suthanthiran, M.30
Wasowska, B.A.31
Zachary, A.32
Zeevi, A.33
more..
-
27
-
-
84857648352
-
Banff meeting report writing committee: Banff 2011 meeting report: New concepts in antibody-mediated rejection
-
MengelM, Sis B, Haas M, Colvin RB, Halloran PF, Racusen LC, Solez K, Cendales L, Demetris AJ, Drachenberg CB, Farver CF, Rodriguez ER, Wallace WD, Glotz D; Banff meeting report writing committee: Banff 2011 meeting report: New concepts in antibody-mediated rejection. Am J Transplant 12: 563-570, 2012.
-
(2012)
Am J Transplant
, vol.12
, pp. 563-570
-
-
Mengel, M.1
Sis, B.2
Haas, M.3
Colvin, R.B.4
Halloran, P.F.5
Racusen, L.C.6
Solez, K.7
Cendales, L.8
Demetris, A.J.9
Drachenberg, C.B.10
Farver, C.F.11
Rodriguez, E.R.12
Wallace, W.D.13
Glotz, D.14
-
28
-
-
84893389755
-
Banff meeting report writing committee: Banff 2013 meeting report: Inclusion of c4d-negative antibody-mediated rejection and antibody-Associated arterial lesions
-
Haas M, Sis B, Racusen LC, Solez K, Glotz D, Colvin RB, CastroMC, David DS, David-Neto E, Bagnasco SM, Cendales LC, Cornell LD, Demetris AJ, Drachenberg CB, Farver CF, Farris AB 3rd, Gibson IW, Kraus E, Liapis H, Loupy A, Nickeleit V, Randhawa P, Rodriguez ER, Rush D, Smith RN, Tan CD, Wallace WD, Mengel M; Banff meeting report writing committee: Banff 2013 meeting report: Inclusion of c4d-negative antibody-mediated rejection and antibody-Associated arterial lesions. Am J Transplant 14: 272-283, 2014.
-
(2014)
Am J Transplant
, vol.14
, pp. 272-283
-
-
Haas, M.1
Sis, B.2
Racusen, L.C.3
Solez, K.4
Glotz, D.5
Colvin, R.B.6
Castro, M.C.7
David, D.S.8
David-Neto, E.9
Bagnasco, S.M.10
Cendales, L.C.11
Cornell, L.D.12
Demetris, A.J.13
Drachenberg, C.B.14
Farver, C.F.15
Farris, A.B.16
Gibson, I.W.17
Kraus, E.18
Liapis, H.19
Loupy, A.20
Nickeleit, V.21
Randhawa, P.22
Rodriguez, E.R.23
Rush, D.24
Smith, R.N.25
Tan, C.D.26
Wallace, W.D.27
Mengel, M.28
more..
-
29
-
-
84886800383
-
Microarray diagnosis of antibody-mediated rejection in kidney transplant biopsies: An international prospective study (INTERCOM)
-
Halloran PF, Pereira AB, Chang J, Matas A, Picton M, De Freitas D, Bromberg J, Serón D, Sellarés J, Einecke G, Reeve J: Microarray diagnosis of antibody-mediated rejection in kidney transplant biopsies: An international prospective study (INTERCOM). Am J Transplant 13: 2865-2874, 2013.
-
(2013)
Am J Transplant
, vol.13
, pp. 2865-2874
-
-
Halloran, P.F.1
Pereira, A.B.2
Chang, J.3
Matas, A.4
Picton, M.5
De Freitas, D.6
Bromberg, J.7
Serón, D.8
Sellarés, J.9
Einecke, G.10
Reeve, J.11
-
30
-
-
84874439800
-
Molecular diagnosis of T cellmediated rejection in human kidney transplant biopsies
-
Reeve J, Sellarés J, MengelM, Sis B, Skene A, Hidalgo L, de Freitas DG, Famulski KS, Halloran PF: Molecular diagnosis of T cellmediated rejection in human kidney transplant biopsies. Am J Transplant 13: 645-655, 2013.
-
(2013)
Am J Transplant
, vol.13
, pp. 645-655
-
-
Reeve, J.1
Sellarés, J.2
Menge, L.M.3
Sis, B.4
Skene, A.5
Hidalgo, L.6
De Freitas, D.G.7
Famulski, K.S.8
Halloran, P.F.9
-
31
-
-
84860604016
-
Molecular phenotypes of acute kidney injury in kidney transplants
-
Famulski K S, de Freitas DG, Kreepala C, Chang J, Sellares J, Sis B, Einecke G, Mengel M, Reeve J, Halloran PF: Molecular phenotypes of acute kidney injury in kidney transplants. J Am Soc Nephrol 23: 948- 958, 2012.
-
(2012)
J Am Soc Nephrol
, vol.23
, pp. 948-958
-
-
Famulski, K.S.1
De Freitas, D.G.2
Kreepala, C.3
Chang, J.4
Sellares, J.5
Sis, B.6
Einecke, G.7
Mengel, M.8
Reeve, J.9
Halloran, P.F.10
-
32
-
-
70349196778
-
Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining
-
Sis B, Jhangri GS, Bunnag S, Allanach K, Kaplan B, Halloran PF: Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining.Am J Transplant 9: 2312-2323, 2009.
-
(2009)
Am J Transplant
, vol.9
, pp. 2312-2323
-
-
Sis, B.1
Jhangri, G.S.2
Bunnag, S.3
Allanach, K.4
Kaplan, B.5
Halloran, P.F.6
-
33
-
-
84860449998
-
Interpreting NK cell transcripts versus T cell transcripts in renal transplant biopsies
-
Hidalgo LG, Sellares J, Sis B, Mengel M, Chang J, Halloran PF: Interpreting NK cell transcripts versus T cell transcripts in renal transplant biopsies. Am J Transplant 12: 1180-1191, 2012.
-
(2012)
Am J Transplant
, vol.12
, pp. 1180-1191
-
-
Hidalgo, L.G.1
Sellares, J.2
Sis, B.3
Mengel, M.4
Chang, J.5
Halloran, P.F.6
-
34
-
-
79951972080
-
Longterm renal allograft survival in the United States: A critical reappraisal
-
Lamb KE, Lodhi S, Meier-Kriesche HU: Longterm renal allograft survival in the United States: A critical reappraisal.Am J Transplant 11: 450-462, 2011.
-
(2011)
Am J Transplant
, vol.11
, pp. 450-462
-
-
Lamb, K.E.1
Lodhi, S.2
Meier-Kriesche, H.U.3
-
35
-
-
0002344794
-
Bootstrap methods: Another look at the jackknife
-
Efron B: Bootstrap methods: Another look at the jackknife. Ann Stat 7: 1-26, 1979.
-
(1979)
Ann Stat
, vol.7
, pp. 1-26
-
-
Efron, B.1
|